Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of MXN 2.69 trillion. The enterprise value is 3.55 trillion.

Market Cap	2.69T
Enterprise Value	3.55T

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 7, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	66.51%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 14.93 and the forward PE ratio is 8.75.

PE Ratio	14.93
Forward PE	8.75
PS Ratio	2.34
PB Ratio	1.58
P/TBV Ratio	n/a
P/FCF Ratio	14.14
P/OCF Ratio	11.22
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.62, with an EV/FCF ratio of 18.65.

EV / Earnings	19.69
EV / Sales	3.11
EV / EBITDA	7.62
EV / EBIT	10.98
EV / FCF	18.65

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 0.67.

Current Ratio	1.28
Quick Ratio	0.90
Debt / Equity	0.67
Debt / EBITDA	2.42
Debt / FCF	5.97
Interest Coverage	6.59

Financial Efficiency

Return on equity (ROE) is 10.60% and return on invested capital (ROIC) is 7.04%.

Return on Equity (ROE)	10.60%
Return on Assets (ROA)	5.19%
Return on Invested Capital (ROIC)	7.04%
Return on Capital Employed (ROCE)	10.33%
Revenue Per Employee	14.23M
Profits Per Employee	2.23M
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.36

Taxes

Income Tax	-12.57B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.70% in the last 52 weeks. The beta is 0.43, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-7.70%
50-Day Moving Average	462.64
200-Day Moving Average	468.22
Relative Strength Index (RSI)	56.20
Average Volume (20 Days)	8,636

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.93

Income Statement

In the last 12 months, Pfizer had revenue of MXN 1.15 trillion and earned 180.41 billion in profits. Earnings per share was 31.69.

Revenue	1.15T
Gross Profit	862.10B
Operating Income	326.30B
Pretax Income	168.00B
Net Income	180.41B
EBITDA	448.94B
EBIT	326.30B
Earnings Per Share (EPS)	31.69

Full Income Statement

Balance Sheet

The company has 275.07 billion in cash and 1.14 trillion in debt, giving a net cash position of -861.80 billion.

Cash & Cash Equivalents	275.07B
Total Debt	1.14T
Net Cash	-861.80B
Net Cash Per Share	n/a
Equity (Book Value)	1.71T
Book Value Per Share	299.57
Working Capital	189.57B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 240.03 billion and capital expenditures -49.58 billion, giving a free cash flow of 190.45 billion.

Operating Cash Flow	240.03B
Capital Expenditures	-49.58B
Free Cash Flow	190.45B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.81%, with operating and profit margins of 28.31% and 15.66%.

Gross Margin	74.81%
Operating Margin	28.31%
Pretax Margin	14.58%
Profit Margin	15.66%
EBITDA Margin	38.96%
EBIT Margin	28.31%
FCF Margin	16.53%

Dividends & Yields

This stock pays an annual dividend of 33.20, which amounts to a dividend yield of 7.05%.

Dividend Per Share	33.20
Dividend Yield	7.05%
Dividend Growth (YoY)	9.31%
Years of Dividend Growth	1
Payout Ratio	98.75%
Buyback Yield	-0.18%
Shareholder Yield	6.87%
Earnings Yield	6.70%
FCF Yield	7.07%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7